You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國家醫保局:將抗原檢測試劑臨時性納入基本醫保醫療服務目錄
阿思達克 03-22 07:24
國家醫保局要求各省級醫療保障部門應根據《新型冠狀病毒肺炎診療方案(試行第九版)》和《新型冠狀病毒肺炎防控方案(試行第九版)》,綜合考慮疫情防控需要、該地區醫保基金支付能力,按照科學精準、積極穩妥、風險可控的原則,及時調整優化醫保相關政策。 最新診療方案顯示,按程序將新冠病毒抗原檢測試劑及相應檢測項目臨時性納入該省份基本醫保醫療服務項目目錄,並新增的奈瑪特韋片/利托那韋片,由醫療機構按照企業與有關部門溝通一致的價格採購,醫保部門按規定做好支付。(ta/s) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account